The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo
- PMID: 11356841
- DOI: 10.1074/jbc.M102174200
The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo
Abstract
The zinc finger-containing transcription factors GATA4 and GATA6 are important regulators of basal and inducible gene expression in cardiac and smooth muscle cell types. Here we demonstrate a direct functional role for GATA4 and GATA6 as regulators of cardiomyocyte hypertrophic growth and gene expression. To model the increase in endogenous GATA4 and GATA6 transcriptional activity that occurs in response to hypertrophic stimulation, each factor was overexpressed in cardiomyocytes using recombinant adenovirus. Overexpression of either GATA4 or GATA6 was sufficient to induce cardiomyocyte hypertrophy characterized by enhanced sarcomeric organization, a greater than 2-fold increase in cell surface area, and a significant increase in total protein accumulation. In vivo, transgenic mice with 2.5-fold overexpression of GATA4 within the adult heart demonstrated a slowly progressing increase in heart to body weight ratio, histological features of cardiomyopathy, and activation of hypertrophy-associated genes, suggesting that GATA factors are sufficient regulators of cardiomyocyte hypertrophy in vitro and in vivo. To evaluate the requirement of GATA factors as downstream transcriptional mediators of hypertrophy, a dominant negative GATA4-engrailed repressor fusion-encoding adenovirus was generated. Expression of GATA4-engrailed blocked GATA4- and GATA6-directed transcriptional responses and agonist-induced cardiomyocyte hypertrophy, demonstrating that cardiac-expressed GATA factors are necessary mediators of this process.
Similar articles
-
The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.Mol Cell Biol. 2001 Nov;21(21):7460-9. doi: 10.1128/MCB.21.21.7460-7469.2001. Mol Cell Biol. 2001. PMID: 11585926 Free PMC article.
-
Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.J Biol Chem. 2005 Feb 11;280(6):4553-67. doi: 10.1074/jbc.M411787200. Epub 2004 Dec 1. J Biol Chem. 2005. PMID: 15574430
-
The transcription factor GATA-6 regulates pathological cardiac hypertrophy.Circ Res. 2010 Oct 15;107(8):1032-40. doi: 10.1161/CIRCRESAHA.110.220764. Epub 2010 Aug 12. Circ Res. 2010. PMID: 20705924 Free PMC article.
-
GATA transcription factors in the developing and adult heart.Cardiovasc Res. 2004 Aug 1;63(2):196-207. doi: 10.1016/j.cardiores.2004.03.025. Cardiovasc Res. 2004. PMID: 15249177 Review.
-
The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression.J Biol Chem. 2000 Dec 15;275(50):38949-52. doi: 10.1074/jbc.R000029200. J Biol Chem. 2000. PMID: 11042222 Review. No abstract available.
Cited by
-
β-catenin/LEF1/IGF-IIR Signaling Axis Galvanizes the Angiotensin-II- induced Cardiac Hypertrophy.Int J Mol Sci. 2019 Sep 2;20(17):4288. doi: 10.3390/ijms20174288. Int J Mol Sci. 2019. PMID: 31480672 Free PMC article.
-
Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts.Mol Cell Biol. 2005 Oct;25(20):8960-70. doi: 10.1128/MCB.25.20.8960-8970.2005. Mol Cell Biol. 2005. PMID: 16199874 Free PMC article.
-
Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.Am J Physiol Heart Circ Physiol. 2006 May;290(5):H1997-2006. doi: 10.1152/ajpheart.01106.2005. Am J Physiol Heart Circ Physiol. 2006. PMID: 16603706 Free PMC article.
-
Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings.Am J Pathol. 2011 May;178(5):2236-51. doi: 10.1016/j.ajpath.2011.01.038. Am J Pathol. 2011. PMID: 21514437 Free PMC article.
-
Loss of YTHDF2 Alters the Expression of m6A-Modified Myzap and Causes Adverse Cardiac Remodeling.JACC Basic Transl Sci. 2023 Jun 21;8(9):1180-1194. doi: 10.1016/j.jacbts.2023.03.012. eCollection 2023 Sep. JACC Basic Transl Sci. 2023. PMID: 37791304 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials